The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians, particularly healthcare providers, to a batch of counterfeit Meronem 1g injection that is currently in circulation.
In a public alert memo released, the agency’s Director-General, Prof. Mojisola Adeyeye, said the Marketing Authorization Holder (MAH), Pfizer, reported the incident, as received through a patient notification platform, concerning a suspicious Meronem 1g injection purchase. She reported Pfizer as saying that the vial content did not dissolve when reconstituted for use and that further visual inspection of the pack was observed.
It was also reported that the crimp code did not match the code reported on the production documentation batch of 2A21F11 and the semi-finished batch used for 4A21I17. Adeyeye added that the production process did not meet Pfizer’s specifications.
“The vial label compares favourably to the purported artwork version. Meronem (Meropenem…
Source: Linda Ikeji
